Does childhood asthma care need an update?

Health Report - Separate stories podcast

Content provided by Australian Broadcasting Corporation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

11d ago 9:39

MP3•Episode home

The guidelines for asthma care in adolescents and adults have been changed, but what about children?

Children aged six to 11 years are still being prescribed the blue puffer as first-line therapy, while older people are prescribed a combination inhaler with a corticosteroid.

Now a major New Zealand study published in the Lancet suggests children should also be swapped over to a combined inhaler to reduce asthma attacks.

Guest/s

Dr Paul Robinson, Professor of Respiratory and Sleep Medicine at Queensland Children’s Hospital and a Research Leader at the Woolcock Research Institute

References

Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial

57 episodes

#Science #Fitness #Australia #Medicine #Australian Broadcasting Corporation #ABC listen